-
Innovation Ranking
NewInnovation Ranking – Hellenic Telecommunications Organization SA
Hellenic Telecommunications Organization SA (OTE) provides fixed and mobile telephony services. The company offers voice, broadband, internet access on 3G and 4G networks; television services; broadband and internet access services; satellite communication; and other related services. It also develops commercial spaces and telecom equipment. The company provides real estate and professional training services. The company also renders financing, e-commerce, retail, wholesale broadband and infrastructure services, electronic money services, ICT and marketing services through its subsidiaries. The company caters its services...
-
Thematic Analysis
NewSupply Chain Disruption – Thematic Intelligence
A supply chain comprises the activities and processes that organizations perform to manufacture and deliver goods and services to consumers. Supply chain disruption occurs when these processes are compromised. The global supply chains organized to optimize profit and speed for over two decades were flipped upside down by the COVID-19 pandemic. Companies had to adopt a just-in-case strategy for their supply chains where hoarding inventory offered a safety net for unforeseen supply chain disruptions.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vilobelimab in Multiple Organ Failure (Multiple Organ Dysfunction Syndrome)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vilobelimab in Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) Drug Details: Vilobelimab (Gohibic) is an...
-
Thematic Analysis
NewGeneric Drugs – Physician Perspective – Thematic Intelligence
Reasons to buy the ‘Generic Drugs – Physician Perspective’ thematic intelligence report: Assess healthcare professionals’ attitudes towards generic drugs prescription. Better understand the barriers to the production and uptake of generic medicines. Capture physicians’ opinions on generics substitution. Better understand patients’ preferences. Assess past and future generics uptake. Gain a better understanding of cost consideration when prescribing drugs. Explore the differences across markets. How is our ‘Generic Drugs – Physician Perspective’ report unique from other reports in the market? This...
-
Sector Analysis
NewAutomotive: Hiring Trends & Signals Q1 2024
The Automotive: Hiring Trends & Signals Q1 2024 report provides valuable insights into hiring trends, job listings, and other important information. The report aims to support decision-making by providing a competitive advantage and a deeper understanding of employment trends, roles, skills, locations, and themes. It delivers critical job insights to corporations and talent/staffing platforms. The report enables competitive analytics and intelligence through proxy signals from job roles, locations, themes and skills. It helps corporations and academia anticipate the future of...
-
Thematic Analysis
NewEnterprise Security Software Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Artificial intelligence (AI) is a double-edged sword in cybersecurity. It can help organizations improve their threat detection, hunting, and incident response capabilities, but adversaries can and will use AI in cyberattacks. There is every likelihood that AI will spur new merger and acquisition (M&A) deals in cybersecurity, especially of companies judged to be AI specialists. In the thematic screen of GlobalData’s enterprise security software sector scorecard, AI has a weighting of 20%, higher than any other theme.
-
Product Insights
Likelihood of Approval Analysis for Shock
Overview How likely is it that the drugs in Shock will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Shock Overview Shock is a medical condition characterized by a significant and life-threatening...
-
Product Insights
Likelihood of Approval Analysis for Transplant Rejection
Overview How likely is it that the drugs in Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Transplant Rejection Overview Transplant rejection is the immune system's response to a...
-
Product Insights
Likelihood of Approval Analysis for Lung Transplant Rejection
Overview How likely is it that the drugs in Lung Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lung Transplant Rejection Overview Lung transplantation is the therapy used in...